Showing results (71-80 of 175) with videos related to

Sort By:
Pageof 18
Diabetes, Obesity & Metabolism|September 13, 2022
Saxagliptin combined with additional oral antihyperglycaemic agents in drug-naive diabetic patients with high glycosylated haemoglobin: A 24-week, multicentre, randomized, open-label, active parallel-controlled group clinical trial in China (SUCCESS)Xiaoping Chen, Hongwei Jiang, Hongmei Li, et al.
The Journal of Endocrinology|November 20, 2012
Involvement of the Ca2+-responsive transactivator in high glucose-induced β-cell apoptosisXiuli Men, Liang Peng, Haiyan Wang, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|January 14, 2014
Metabolic syndrome and chronic kidney disease in general Chinese adults: results from the 2007-08 China National Diabetes and Metabolic Disorders StudyJie Ming, Shaoyong Xu, Chao Yang, et al.
Diabetes, Obesity & Metabolism|October 19, 2020
Efficacy and safety of linagliptin as add-on therapy to insulin in Chinese patients with type 2 diabetes mellitus: A randomized, double-blind, placebo-controlled trialWenying Yang, Xiangjin Xu, Tao Lei, et al.
Discovery Medicine|April 27, 2025
Effects of Botulinum Toxin A on Condylar Subchondral Bone MassLinqing Tian, Ye He, Wenli Zhang, et al.
Plos One|November 21, 2012
Involvement of dynamin-related protein 1 in free fatty acid-induced INS-1-derived cell apoptosisLiang Peng, Xiuli Men, Wenjian Zhang, et al.
Diabetes Research and Clinical Practice|August 26, 2018
Stronger associations of waist circumference and waist-to-height ratio with diabetes than BMI in Chinese adultsXuhong Hou, Siyu Chen, Gang Hu, et al.
International Journal of Molecular Medicine|May 4, 2011
Dynamin-related protein 1 is implicated in endoplasmic reticulum stress-induced pancreatic β-cell apoptosisLiang Peng, Xiuli Men, Wenjian Zhang, et al.
Diabetes Technology & Therapeutics|January 7, 2017
"Learning" Can Improve the Blood Glucose Control Performance for Type 1 Diabetes MellitusYouqing Wang, Jinping Zhang, Fanmao Zeng, et al.
Advances in Therapy|November 10, 2021
Influence of Fasting Plasma Glucose Targets on Glycemic Variability in Chinese Participants With Type 2 Diabetes: A Post Hoc Analysis of the FPG GOAL Trial (BEYOND III)Ling Li, Tao Yang, Yaoming Xue, et al.
Pageof 18